UNITED STATES: Congress set to back Medicare reform
You must be signed in to read this analysis
In this article
- Sectoral impact
- Doctors and hospitals
- Health plans and insurers
- Pharmaceutical companies
- Prescription drug plans
- Import ban
- Drug prices
- Pharmacies and PBMs
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.